RÉSUMÉ
A prevalência de HIV em travestis e mulheres transexuais (TrMT) é desproporcionalmente maior quando comparada com a população geral do Brasil. O objetivo deste estudo foi analisar por meio de ensaios molecular e sorológicos convencionais para o diagnóstico da infecção pelo HIV amostras de sangue de uma população TrMT de cinco capitais brasileiras que apresentaram resultado reagente em testes rápidos (TR). Um total de 435 amostras com resultado reagente em pelo menos um TR foi encaminhado ao laboratório de referência do estado de São Paulo o Instituto Adolfo Lutz (IAL) para que fossem analisadas, por meio de testes laboratoriais convencionais. Das amostras avaliadas, 99,3% (432/435) foram reagentes para HIV nos testes laboratoriais convencionais, e destas, 22,7% (98/432) apresentaram carga viral HIV-1 acima de 5.000 cópias/mL e 77,3% (334/432) mostraram-se reagentes em testes sorológicos (imunoensaio de quimioluminescência ou ELISA e imunoblot rápido). As três amostras restantes (0,7%) foram classificadas como "indeterminada para HIV", com base em ensaios molecular e sorológicos convencionais. A sensibilidade analítica dos diferentes ensaios molecular e sorológicos utilizados neste estudo pode ter variado pela influência da imunossupressão viral do HIV-1 resultante da terapia antirretroviral (TARV). Estudos complementares são necessários para melhor entender o impacto da terapia no diagnóstico do HIV
HIV prevalence among travestis and transgender women (TrTW) is disproportionately higher when compared to the overall Brazilian population. The objective of this study was to evaluate, through conventional serological and molecular tests for the diagnosis of HIV infection, blood samples of TrTW residents of five Brazilian capitals with previous reactive HIV point-of-care rapid tests (RT). A total of 435 samples with at least one reactive HIV result on point-of-care tests were sent to the HIV reference laboratory in São Paulo State the Adolfo Lutz Institute for further evaluation by conventional laboratory tests. From total, 432 (99.3%) samples were reactive for HIV infection in conventional laboratory assays, comprising 98/432 (22.7%) with HIV-1 viral load over 5,000 copies/ml, and 334/432 (77.3%) reactive to serological tests (chemiluminescence immunoassay or ELISA, and rapid immunoblotting). The three remaining samples (0.7%) were classified as "indeterminate for HIV" based on conventional serological and molecular assays. Analytical sensitivity of different molecular and serological assays used in this study may have varied due to HIV-1 viral suppression resulting from antiretroviral therapy (ART). Additional studies are needed to better understand the impact of therapy on HIV diagnosis
Sujet(s)
Brésil , Dosage immunologique , Anticorps anti-VIH , Charge virale , Thérapie antirétrovirale hautement active , Personnes transgenres , Tests de diagnostic rapideRÉSUMÉ
Herpes virus 2 (HSV-2) is the main cause of genital herpes, one of the most prevalent sexually transmitted infections (STIs) in the world. STIs are major public health problems in prisons because of the behaviors of prisoners and the presence of other factors that increase the risk of transmission. The present study aimed to estimate the prevalence and risk factors associated with HSV-2 infection at 12 prisons in Mato Grosso of Sul, Brazil. We tested 872 serum samples (732 from males, 140 from females) for anti-HSV-2 IgG, and tested the positive samples (n = 184) for anti-HSV-2 IgM. Anti-HSV-2 IgG positivity (n = 85, 43.1%, 95% CI = 34.6 to 40.4). The prevalence of HSV-2 positivity was much greater than reported in the general population of Brazil and in other prison populations worldwide. There was a greater risk of HSV-2 positivity in prisoners who were older, female, unmarried, HIV positive, positive for other STIs, not previously incarcerated, in the same cell with more than 26 individuals, and in those who reported having had genital discharge in the past month, having had a homosexual relationship in recent months, and not using or occasionally not using condoms during sexual intercourse. Further analysis of prisoners with active HSV-2 infections (anti-HSV-2 IgM positivity) indicated that unmarried status and the presence of 26 or more prisoners in the same cell increased the risk for active HSV-2 infection. This study provides important data on HSV-2 seroprevalence in the prison population of Brazil, and identified risk factors associated with HSV-2 infection. These data provide important information needed to implement procedures that better prevent and control of STIs in prison populations..
RÉSUMÉ
INTRODUCTION: This paper details the methods used in the second national Biological and Behavioral Surveillance Survey (BBSS) of HIV, syphilis, and hepatitis B and C among men who have sex with men in Brazil. METHODS: Respondent-driven sampling (RDS) was used in 12 cities in 2016. The targeted sample size was initiated with five to six seeds in each city. HIV, syphilis, and Hepatitis B and C rapid tests were offered to participants. RDS Analyst with Gile's successive sampling (SS) estimator was used to adjust results as recommended and a weight for each individual was generated for further analysis. Data for the 12 cities were merged and analyzed using Stata 14.0 complex survey data tools with each city treated as its own stratum. RESULTS: Duration of data collection varied from 5.9 to 17.6 weeks. 4,176 men were recruited in the 12 cities. Two sites failed to achieve targeted sample size due to a six-month delay in local IRB approval. No city failed to reach convergence in our major outcome variable (HIV). CONCLUSION: The comprehensive BBSS was completed as planned and on budget. The description of methods here is more detailed than usual, due to new diagnostic tools and requirements of the new STROBE-RDS guidelines.
Sujet(s)
Infections à VIH/diagnostic , Hépatite B/diagnostic , Hépatite C/diagnostic , Homosexualité masculine/statistiques et données numériques , Syphilis/diagnostic , Adulte , Brésil/épidémiologie , Infections à VIH/épidémiologie , Enquêtes de santé/méthodes , Hépatite B/épidémiologie , Hépatite C/épidémiologie , Humains , Mâle , Surveillance de la population , Prévalence , Autorapport , Enquêtes et questionnaires , Syphilis/épidémiologieRÉSUMÉ
ABSTRACT: Introduction: This paper details the methods used in the second national Biological and Behavioral Surveillance Survey (BBSS) of HIV, syphilis, and hepatitis B and C among men who have sex with men in Brazil. Methods: Respondent-driven sampling (RDS) was used in 12 cities in 2016. The targeted sample size was initiated with five to six seeds in each city. HIV, syphilis, and Hepatitis B and C rapid tests were offered to participants. RDS Analyst with Gile's successive sampling (SS) estimator was used to adjust results as recommended and a weight for each individual was generated for further analysis. Data for the 12 cities were merged and analyzed using Stata 14.0 complex survey data tools with each city treated as its own stratum. Results: Duration of data collection varied from 5.9 to 17.6 weeks. 4,176 men were recruited in the 12 cities. Two sites failed to achieve targeted sample size due to a six-month delay in local IRB approval. No city failed to reach convergence in our major outcome variable (HIV). Conclusion: The comprehensive BBSS was completed as planned and on budget. The description of methods here is more detailed than usual, due to new diagnostic tools and requirements of the new STROBE-RDS guidelines.
RESUMO: Introdução: Este artigo detalha os métodos utilizados na segunda Pesquisa Nacional de Vigilância Biológica e Comportamental (BBSS) do HIV, sífilis e hepatite B e C entre os homens que fazem sexo com homens no Brasil. Métodos: O método Respondent-driven Sampling (RDS) foi utilizado em 12 cidades em 2016. A amostra foi iniciada com cinco a seis sementes em cada cidade. Testes rápidos para o HIV, sífilis e Hepatite B e C foram oferecidos aos participantes. O software RDS Analyst com o estimador de amostragem sucessiva (SS) de Gile foi utilizado para ajustar os resultados como recomendado, gerando um peso para cada indivíduo para análises. Osdados das 12cidades foram unidos em um único banco e analisados usando as ferramentas de dados complexos do Stata 14.0, com cada cidade sendo tratada como seu próprio estrato. Resultados: A duração da coleta de dados variou de 5,9 a 17,6 semanas e 4.176 homens foram recrutados nas 12 cidades. Dois sites não alcançaram o tamanho da amostra alvo devido a uma demora de seis meses na aprovação local do Comitê de Ética. Todas as cidades atingiram a convergência na principal variável estudada (HIV). Conclusão: O BBSS foi representativo e concluído conforme planejado e dentro do orçamento. A descrição dos métodos aqui é mais detalhada do que o habitual, devido às novas ferramentas e requisitos de diagnóstico das novas diretrizes do STROBE-RDS.
Sujet(s)
Humains , Mâle , Adulte , Syphilis/diagnostic , Infections à VIH/diagnostic , Hépatite C/diagnostic , Homosexualité masculine/statistiques et données numériques , Hépatite B/diagnostic , Brésil/épidémiologie , Syphilis/épidémiologie , Infections à VIH/épidémiologie , Surveillance de la population , Prévalence , Enquêtes et questionnaires , Enquêtes de santé/méthodes , Hépatite C/épidémiologie , Autorapport , Hépatite B/épidémiologieRÉSUMÉ
O objetivo deste estudo foi identificar os principais subtipos de HIV-1 circulantes no Mato Grosso do Sul (MS), Brasil Central. Métodos: Trata-se de um estudo transversal de séries temporais com dados de laboratório e relato de doença, analisados por período de diagnóstico e variáveis sociodemográficas e clínicas. Resultados: Subtipo B HIV-1 predominou quando os períodos foram analisados (85,4% vs 85,3%). Além disso, foi detectado um aumento na frequência do subtipo C do HIV-1, mas nenhuma diferença significativa foi observada entre os dois períodos. Após análise univariada, a faixa etária entre 25 e 45 anos (p = 0,004) e o gênero masculino (p = 0,04) mostraram-se associados ao subtipo B HIV-1. Os achados relacionados à resistência do HIV-1 à ARV mostraram que 30,6% dos pacientes diagnosticados com AIDS entre 1985 e 2012, submetidos a testes de genotipagem (212), eram resistentes a mais de três classes de ARVs (MDR). Conclusões: Estudos sobre a diversidade genética, bem como o perfil de mutações de resistência no HIV-1, são ferramentas importantes para a reconstrução histórica de epidemias regionais, vigilância epidemiológica local e diretrizes de tratamento.
The objective of this study was to identify the major subtypes of HIV-1 circulating in Mato Grosso do Sul (MS), Central Brazil. Methods:This is a cross-sectional study of time series with data from laboratory and disease report, analyzed by period of diagnosis and sociodemographic and clinical variables. Results: Subtype B HIV-1 predominated when periods were analyzed (85.4% vs 85.3%). In addition, an increase in the frequency of HIV-1 subtype C was detected, but no significant difference was seen between the two periods. After univariate analysis, the age range between 25 and 45 years (p = 0.004) and the masculine gender (p = 0.04) were found to be associated with subtype B HIV-1. The findings related to the resistance of HIV-1 to ARV showed that 30.6% of the investigated patients diagnosed AIDS between 1985 and 2012 who underwent genotyping tests (212) were resistant to more than three ARV classes (MDR). Conclusions: Studies on the genetic diversity, as well as the profile of resistance mutations in HIV-1, are important tools for both the historical reconstruction of regional epidemics and local epidemiological surveillance and treatment guidelines.
Sujet(s)
Humains , VIH-1 (Virus de l'Immunodéficience Humaine de type 1) , Infections , Patients , Études de Séries TemporellesRÉSUMÉ
This paper reports human immuno-deficiency virus (HIV) prevalence in the 2nd National Biological and Behavioral Surveillance Survey (BBSS) among men who have sex with men (MSM) in 12 cities in Brazil using respondent-driven sampling (RDS).Following formative research, RDS was applied in 12 cities in the 5 macroregions of Brazil between June and December 2016 to recruit MSM for BBSS. The target sample size was 350 per city. Five to 6 seeds were initially selected to initiate recruitment and coupons and interviews were managed online. On-site rapid testing was used for HIV screening, and confirmed by a 2nd test. Participants were weighted using Gile estimator. Data from all 12 cities were merged and analyzed with Stata 14.0 complex survey data analysis tools in which each city was treated as its own strata. Missing data for those who did not test were imputed HIV+ if they reported testing positive before and were taking antiretroviral therapy.A total of 4176 men were recruited in the 12 cities. The average time to completion was 10.2 weeks. The longest chain length varied from 8 to 21 waves. The sample size was achieved in all but 2 cities.A total of 3958 of the 4176 respondents agreed to test for HIV (90.2%). For results without imputation, 17.5% (95%CI: 14.7-20.7) of our sample was HIV positive. With imputation, 18.4% (95%CI: 15.4-21.7) were seropositive.HIV prevalence increased beyond expectations from the results of the 2009 survey (12.1%; 95%CI: 10.0-14.5) to 18.4%; CI95%: 15.4 to 21.7 in 2016. This increase accompanies Brazil's focus on the treatment to prevention strategy, and a decrease in support for community-based organizations and community prevention programs.
Sujet(s)
Infections à VIH/épidémiologie , Homosexualité masculine/statistiques et données numériques , Adulte , Brésil/épidémiologie , Humains , Mâle , Dépistage de masse/statistiques et données numériques , Prévalence , Enquêtes et questionnaires , Jeune adulteRÉSUMÉ
INTRODUÇÃO: Estudos anteriores relataram maior prevalência de Tuberculose e HIV entre os prisioneiros do que na população geral no Brasil, mas existem dados limitados disponíveis para facilitar o desenvolvimento de intervenções efetivas neste cenário de alta transmissão. O objetivo deste estudo foi avaliar a prevalência e os fatores de risco associados à Tuberculose e ao HIV. METODOLOGIA: Realizado questionário para a amostra de detentos de 12 prisões em Mato Grosso do Sul (Brasil), prova tuberculínica, coletado sangue para teste de HIVe duas amostras de escarro para baciloscopia e cultura de participantes que relataram tosse de qualquer duração, de Janeiro a Dezembro de2013. RESUILTADOS: Foram recrutados 3.380 detentos, dos quais 2.861(84,6%) eram homens de 8 prisões e 519 (15,4%) eram mulheres de4 prisões. Entre os 1.020 (30%) indivíduos que relataram tosse, 691(68%) coletaram escarro e foram identificados 31 casos de tuberculose ativa, com uma prevalência de 917 por 100.000 detentos. A prevalência de tuberculose latente foi de 22,5% e 11,7% para homens e mulheres,respectivamente. Dos participantes, 55 (1,63%) são soropositivos: 45(1,58%) homens e 10 mulheres (1,93%). CONCLUSÕES: Observou-se que a prevalência de tuberculose ativa e HIV são mais elevadas entre detentos do que na população geral, o que indica um alto risco de infecção e transmissão dentro dessas configurações. Para melhorar o controle da tuberculose nas prisões é necessária a detecção de casos de TB ativa em presídios através da triagem frequente e detecção de casos passiva e ativa.
BACKGROUND: Prior studies have reported higher Tuberculosis and HIVprevalence among prisoners than the general population in Brazil, yet there are limited data available to facilitate the development of effectiveinterventions in this high-transmission setting. The aim of this study wasto evaluate the prevalence and risk factors associated with TB and HIV. METHODS: We administered a questionnaire and tuberculin skin test (TST)to a population-based sample of inmates from 12 prisons in Mato Grasso do Sul (Brazil) and collected sera for HIV testing and two sputum samplesfor smear microscopy and culture from participants reporting a cough ofany duration, from January to December 2013. RESULTS: We recruited 3,380inmates, of which 2,861 (84.6%) were males from 8 prisons, and 519(15.4%) were females from 4 prisons. Among the 1,020 (30%) subjectswho reported a cough, we obtained sputum from 691 (68%) and identified31 cases of active TB for a prevalence of 917 per 100,000 prisoners. The prevalences of LTBI were 22.5% and 11.7% for male and female prisoners, respectively. Of these participants, 55 (1.63%) tested HIV-positive: 45(1.58%) men and 10 women (1.93%). It is observed that the prevalence ofTB and HIV are higher in prisons than in urban populations, indicating ahigh risk of infection and transmission within these settings. CONCLUSIONS: It is observed that the prevalence of Tuberculose and HIV are higher inprisons than in urban populations, indicating a high risk of infection andtransmission within these settings. For enhancing TB control in prisons is necessary case detection for active TB in prison facilities through frequent screening and passive and active case-finding of inmates.
Sujet(s)
Mâle , Femelle , Humains , Tuberculose , VIH (Virus de l'Immunodéficience Humaine) , Prisonniers , Études transversales , Épidémiologie , Contrôle des maladies transmissibles , Maladies sexuellement transmissiblesRÉSUMÉ
BACKGROUND: Melanoma inhibitory activity is a protein secreted by melanoma cells and has been used as a tumor marker. Increased Melanoma inhibitory activity serum levels are related to metastatic disease or tumor recurrence. Currently there are no studies on Melanoma inhibitory activity and cutaneous melanoma involving Brazilian patients. OBJECTIVE: To evaluate the performance and feasibility of measuring Melanoma inhibitory activity levels in Brazilian patients with cutaneous melanoma. METHODS: Blood was obtained from ten patients with proved metastatic cutaneous melanoma (Group 1), 15 patients resected for cutaneous melanoma without metastasis (Group 2) and 5 healthy donors (Group 3). Melanoma inhibitory activity was measured using a commercially available ELISA kit. RESULTS: There was a statistically significant difference of Melanoma inhibitory activity levels between patients with and without metastasis (p=0.002), and between patients with metastasis and healthy donors (p=0.002). There was no difference between patients without metastasis and healthy donors (p=0.443). CONCLUSION: Melanoma inhibitory activity is a tumor marker for cutaneous melanoma and the Melanoma inhibitory activity-ELISA test can be easily performed. Patients with metastasis have increased Melanoma inhibitory activity serum levels when compared to patients without metastasis and healthy donors.
Sujet(s)
Protéines de la matrice extracellulaire/sang , Mélanome/sang , Protéines tumorales/sang , Tumeurs cutanées/sang , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Brésil , Études cas-témoins , Test ELISA , Études de faisabilité , Humains , Mélanome/anatomopathologie , Mélanome/secondaire , Adulte d'âge moyen , Métastase tumorale , Valeurs de référence , Reproductibilité des résultats , Tumeurs cutanées/anatomopathologie , Tumeurs cutanées/secondaire , Statistique non paramétriqueRÉSUMÉ
Population-based prevalence studies are essential tools for screening of hepatitis A and provide important data on susceptible groups. However, surveillance in isolated communities is difficult because of the limited access to these areas and the need for blood sample collection. This study aimed to determine the anti-HAV prevalence using oral fluid samples to provide an alternative tool for epidemiological studies that might be useful for vaccination-related decisions. The study population was composed of 224 volunteers from South Pantanal, aged 3 to 86 years old. This study was performed using oral fluids, previously standardized for anti-HAV antibody detection, which were collected using a ChemBio device. Eluates were tested using modified commercial EIA to detect anti-HAV antibodies. The overall prevalence was 79.1%, corresponding to 178 reactive EIA tests out of 224 samples. The age stratified data revealed a prevalence of 47.8% between 0-10 years, 84% in 11-20 years and 91.9% in subjects older than 21 years. Results indicate that hepatitis A prevalence was higher in adolescents and adults, corroborating the literature reports. Thus, oral fluid samples could replace serum in HAV epidemiological studies in isolated communities as they are efficient at detecting anti-HAV antibodies.
Sujet(s)
Anticorps de l'hépatite A/analyse , Hépatite A/épidémiologie , Salive/composition chimique , Vaccination/statistiques et données numériques , Vaccins/usage thérapeutique , Adolescent , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Brésil/épidémiologie , Enfant , Enfant d'âge préscolaire , Études transversales , Femelle , Anticorps de l'hépatite A/sang , Humains , Mâle , Adulte d'âge moyen , Prévalence , Études séroépidémiologiques , Jeune adulteRÉSUMÉ
Abstract BACKGROUND: Melanoma inhibitory activity is a protein secreted by melanoma cells and has been used as a tumor marker. Increased Melanoma inhibitory activity serum levels are related to metastatic disease or tumor recurrence. Currently there are no studies on Melanoma inhibitory activity and cutaneous melanoma involving Brazilian patients. OBJECTIVE: To evaluate the performance and feasibility of measuring Melanoma inhibitory activity levels in Brazilian patients with cutaneous melanoma. METHODS: Blood was obtained from ten patients with proved metastatic cutaneous melanoma (Group 1), 15 patients resected for cutaneous melanoma without metastasis (Group 2) and 5 healthy donors (Group 3). Melanoma inhibitory activity was measured using a commercially available ELISA kit. RESULTS: There was a statistically significant difference of Melanoma inhibitory activity levels between patients with and without metastasis (p=0.002), and between patients with metastasis and healthy donors (p=0.002). There was no difference between patients without metastasis and healthy donors (p=0.443). CONCLUSION: Melanoma inhibitory activity is a tumor marker for cutaneous melanoma and the Melanoma inhibitory activity-ELISA test can be easily performed. Patients with metastasis have increased Melanoma inhibitory activity serum levels when compared to patients without metastasis and healthy donors. .
Sujet(s)
Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Humains , Adulte d'âge moyen , Protéines de la matrice extracellulaire/sang , Mélanome/sang , Protéines tumorales/sang , Tumeurs cutanées/sang , Brésil , Études cas-témoins , Test ELISA , Études de faisabilité , Mélanome/anatomopathologie , Mélanome/secondaire , Métastase tumorale , Valeurs de référence , Reproductibilité des résultats , Statistique non paramétrique , Tumeurs cutanées/anatomopathologie , Tumeurs cutanées/secondaireRÉSUMÉ
OBJECTIVES: To evaluate the hepatitis B immunization status of female sex workers (FSWs) in Central-West Brazil and to evaluate their compliance with and immune response to hepatitis B vaccination delivered using outreach strategies. METHODS: A total of 721 FSWs recruited in 2 large cities in Central-West Brazil were interviewed and screened for the presence of hepatitis B virus (HBV) markers. Hepatitis B vaccine was offered to all women susceptible to HBV, using outreach strategies. The immune response of FSWs who received a full course of vaccine was assessed following the final vaccine dose. RESULTS: We found that 27.6% of FSWs, the majority of whom were aged 18 to 25 years, had serological evidence of previous hepatitis B vaccination. A total of 434 FSWs were eligible for vaccination, 389 (89.6%) of whom accepted the first hepatitis B vaccine dose. Of those, 64% received a second dose and 37.5% received all three doses. Through the outreach strategy, there was a 52.2% increase in the number of women who received the second dose and a 67% increase in the number who received the third dose. Of the 146 women who received a full course of vaccine, 105 accepted testing for quantitative anti-HBs (hepatitis B surface antibody) following the final vaccine dose, and 92.4% of those tested had developed protective levels of anti-HBs. Lower education level, workplace, and length of prostitution were predictors of full-vaccine acceptance. CONCLUSIONS: The present findings illustrate the benefits of using outreach strategies to overcome the difficulties of vaccinating hard-to-reach populations such as FSWs.
Sujet(s)
Anticorps de l'hépatite B/sang , Vaccins anti-hépatite B/immunologie , Hépatite B chronique/prévention et contrôle , Immunisation/statistiques et données numériques , Observance par le patient/statistiques et données numériques , Travailleurs du sexe/statistiques et données numériques , Vaccination/statistiques et données numériques , Adolescent , Adulte , Brésil , Femelle , Hépatite B/immunologie , Humains , Jeune adulteRÉSUMÉ
A strategy adopted by different countries to reduce the number of new cases of hepatitis A is the vaccination. However, the mosaic of the epidemiological profile in developing countries has hampered the establishment of a unified nationwide vaccination program. To determinate national vaccination policies, the results of epidemiological studies need to be carefully considered. For this monitoring, the use of oral fluid is very important due to the painless and non invasive collection characteristics. There are few studies investigating which oral fluid collection device is optimal to detect low antibody levels and its use in selecting individuals for vaccination. So, the present study aimed to evaluate different oral fluid collection devices to detect humoral immune response against hepatitis A virus and its application in epidemiological studies. Therefore, 90 matched serum and oral fluid samples were collected from volunteers with different immune status, under ideal conditions of collection (optimization panel); and 224 matched samples in difficult-to-access areas (epidemiological study). Serum was collected by venipuncture and the oral fluid was obtained using three commercial devices: Salivette(®), OraSure(®) and ChemBio(®). Serum and oral fluid were submitted to a commercial immunoblot to detect total anti-HAV antibodies. The optimization panel demonstrated that ChemBio(®) device had the best performance (100% agreement), followed by OraSure(®) (95.4%) and Salivette(®) (90.8%). The optimal collection device (ChemBio(®)), tested in a difficult-to-access area and evaluated under precarious conditions of collection, showed similar prevalence of total anti-HAV between serum and oral fluid, 80.8% and 79%, respectively. A follow-up was performed to evaluate the stability of oral fluid and it was observed that 210 days after the collection it was possible to detect anti-HAV antibodies. Oral fluid can be used to detect low levels of specific-antibody, being important to select age groups to be vaccinated. Therewith, the choice of proper collection device is essential to evaluate HAV antibodies in the epidemiological scenario.
Sujet(s)
Anticorps de l'hépatite A/analyse , Hépatite A/épidémiologie , Salive/virologie , Adolescent , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Enfant , Enfant d'âge préscolaire , Femelle , Anticorps de l'hépatite A/sang , Vaccins anti-hépatite A/administration et posologie , Humains , Mâle , Adulte d'âge moyen , Surveillance de la population , Valeur prédictive des tests , Sensibilité et spécificité , Manipulation d'échantillons , Jeune adulteRÉSUMÉ
Estudos recentes sobre o torque teno vírus (TTV), gênero Anellovirus, permitiram construir a hipótese de que esse vírus pode ser um desencadeante ou tenha algum papel patogênico nas doenças reumáticas autoimunes. OBJETIVOS: Verificar a frequência da infecção pelo TTV em pacientes com lúpus eritematoso sistêmico (LES), e sua diversidade gênica, a existência de correlação entre a infecção pelo TTV e as manifestações clínicas do LES, sua evolução clínica e o perfil sorológico. PACIENTES E MÉTODOS: Foram obtidas 46 amostras de soro de pacientes com LES atendidos no Ambulatório de Reumatologia do Hospital Universitário de Campo Grande (NHU/FAMED/UFMS). Para os controles, utilizaram-se 46 amostras de soro de doadores de sangue. O DNA viral foi extraído das amostras utilizando o QIAamp DNA Blood Mini Kit (QIAGEN, Hilden, Alemanha), e amplificado utilizando a técnica de nested PCR. RESULTADOS: Foi encontrada positividade para o TTV em 17 (37 por cento) dos pacientes lúpicos, e em apenas sete (15,2 por cento) dos controles (teste z, P = 0,03). Não houve correlação entre a infecção pelo TTV, as manifestações clínicas, o perfil sorológico e a evolução clínica dos pacientes avaliados neste estudo. CONCLUSÃO: A presença do TTV nos pacientes com LES necessita ser mais bem compreendida a partir deste estudo inicial.
Recent studies on the torque teno virus (TTV), genus Anellovirus, have allowed formulating the hypothesis that TTV may trigger autoimmune rheumatic diseases or have some pathogenic role in them. OBJECTIVES: To determine the frequency of TTV infection in patients with systemic lupus erythematosus (SLE), the genetic diversity of TTV, the correlation between TTV infection and SLE clinical manifestations, and SLE clinical course and serological profile. PATIENTS AND METHODS:Serum samples were obtained from 46 SLE patients treated at the University-Affiliated Hospital of Campo Grande (NHU/FAMED/UFMS), Brazil. For controls, serum samples were obtained from 46 healthy volunteer blood donors. Viral DNA was extracted from samples using the QIAamp DNA Blood Mini Kit (QIAGEN, Hilden, Germany) and amplified using nested PCR. RESULTS: Positivity for TTV was found in 17 (37 percent) of SLE patients and in only seven (15.2 percent) of the controls (z test, P = 0.03). There was no correlation between TTV infection, SLE clinical manifestations, SLE clinical course, and the serological profile of the patients evaluated. CONCLUSION: Further studies on the presence of TTV in SLE patients are required.
Sujet(s)
Adolescent , Adulte , Femelle , Humains , Mâle , Adulte d'âge moyen , Jeune adulte , Infections à virus à ADN/complications , Infections à virus à ADN/épidémiologie , Lupus érythémateux disséminé/complications , Virus torque teno/génétique , Brésil , Infections à virus à ADN/sang , Variation génétique , Lupus érythémateux disséminé/sang , PrévalenceRÉSUMÉ
UNLABELLED: Recent studies on the torque teno virus (TTV), genus Anellovirus, have allowed formulating the hypothesis that TTV may trigger autoimmune rheumatic diseases or have some pathogenic role in them. OBJECTIVES: To determine the frequency of TTV infection in patients with systemic lupus erythematosus (SLE), the genetic diversity of TTV, the correlation between TTV infection and SLE clinical manifestations, and SLE clinical course and serological profile. PATIENTS AND METHODS: Serum samples were obtained from 46 SLE patients treated at the University-Affiliated Hospital of Campo Grande (NHU/FAMED/UFMS), Brazil. For controls, serum samples were obtained from 46 healthy volunteer blood donors. Viral DNA was extracted from samples using the QIAamp DNA Blood Mini Kit (QIAGEN, Hilden, Germany) and amplified using nested PCR. RESULTS: Positivity for TTV was found in 17 (37%) of SLE patients and in only seven (15.2%) of the controls (z test, P = 0.03). There was no correlation between TTV infection, SLE clinical manifestations, SLE clinical course, and the serological profile of the patients evaluated. CONCLUSION: Further studies on the presence of TTV in SLE patients are required.
Sujet(s)
Infections à virus à ADN/complications , Infections à virus à ADN/épidémiologie , Lupus érythémateux disséminé/complications , Virus torque teno/génétique , Adolescent , Adulte , Brésil , Infections à virus à ADN/sang , Femelle , Variation génétique , Humains , Lupus érythémateux disséminé/sang , Mâle , Adulte d'âge moyen , Prévalence , Jeune adulteRÉSUMÉ
INTRODUCTION: Hepatic disorders caused by dengue infection may progress to severe manifestations, including mortality and morbidity. Cytokines are involved in it, such as the migration inhibitory factor of macrophages (MIF), tumor necrosis factor (TNF), natural killer cells (NK), B lymphocytes, and macrophages. METHODS: This study was carried out from January to April 2007 at a public hospital from the Federal University of Mato Grosso do Sul, Campo Grande, Brazil. Sixty-eight patients were studied concerning hepatic alterations, with 56 reported having classic dengue, 6 with hemorrhagic dengue grade I, and 6 with hemorrhagic dengue grade II. RESULTS: Among the 56 with classic dengue, 83.3 percent had aspartate aminotransferase (AST) alterations, and 69.6 percent had altered alanine aminotransferase (ALT). For those with hemorrhagic dengue grade I, 100 percent had AST alterations, and 83.3 percent had altered ALT. All the patients with hemorrhagic dengue grade II had AST and ALT alterations. AST variations reached 22.0 and 907.0, with an average value of 164.6. For ALT, we found variations between 25.0 and 867.0, with an average value of 166.07. There had been statistical significance between dengue clinical shapes and hepatic function markers. CONCLUSIONS: We conclude that the infection was predominant in adults, females, and in those with low income and education. The liver enzymes were of larger amount in hemorrhagic dengue, but there was weak statistical evidence of the clinical manifestations and transaminases. Major signs and clinical symptoms were fever, headache, myalgia, arthralgia, weakness, severe pain behind the eyes, and rashes.
INTRODUÇÃO: Afecções hepáticas causadas pela infecção da dengue podem evoluir para quadro grave, incluindo mortalidade e morbidade. O mecanismo de lesão do fígado está relacionado com a exacerbação da resposta imune. As citocinas estão envolvidas nele como fator inibidor da migração de macrófagos (MIF), fator de necrose tumoral (TNF), células natural killer (NK), B linfócitos e macrófagos. MÉTODOS: Este estudo foi realizado em um hospital público da Universidade Federal do Mato Grosso do Sul. As alterações hepáticas pelo dengue podem evoluir com quadros graves e potencialmente letais. Foram avaliados exames de 68 pacientes atendidos e confirmados com dengue, onde 56 foram classificados como dengue clássico, seis, como dengue hemorrágico grau I e seis como dengue hemorrágico grau II. RESULTADOS: Do dengue clássico, 83,3 por cento tiveram alterações de aspartato aminotransferase (AST) e 69,6 por cento alterações para alanino aminotransferase (ALT). No dengue hemorrágico grau I, AST elevou-se 100 por cento e para ALT 83,3 por cento. No dengue hemorrágico grau II observou-se 100 por cento de alterações tanto para AST, quanto para ALT. A variação de AST ficou entre 22,0 e 907,0 com média de 164,6. A alanino aminotransferase variou entre 25,0 e 867,0 com média de 166,07. Houve significância entre formas clínicas do dengue e marcadores de função hepática. CONCLUSÕES: Conclui-se que a infecção predominou em adultos do sexo feminino, de baixa renda e escolaridade. As enzimas hepáticas elevam-se mais no dengue hemorrágico, fraca evidência estatística entre as manifestações clínicas e as transaminases. Os mais prevalentes sinais/sintomas clínicos foram febre, cefaléia, mialgia, artralgia, fraqueza, dor retrorbitária e exantema.
Sujet(s)
Adulte , Sujet âgé , Femelle , Humains , Mâle , Adulte d'âge moyen , Jeune adulte , Marqueurs biologiques/sang , Dengue/complications , Maladies du foie/virologie , Alanine transaminase/sang , Aspartate aminotransferases/sang , Dengue sévère/sang , Dengue sévère/complications , Dengue/sang , Maladies du foie/sang , Indice de gravité de la maladie , Facteurs socioéconomiquesRÉSUMÉ
O estudo teve por objetivo estimar a prevalência da infecção e genótipo do vírus da hepatite C (HCV), bem como determinar a subnotificação de casos. O total de 115.386 gestantes atendidas pelo Programa Estadual de Proteção à Gestante de Mato Grosso do Sul foi submetido à coleta de sangue para a detecção de anti-HCV, de 2005 a 2007. A prevalência da infecção pelo HCV foi de 1,07 casos/1.000. As amostras positivas foram submetidas à detecção do HCV-RNA e genotipadas. O genótipo 1 foi encontrado em 73 por cento das amostras, 24,3 por cento pertenciam ao genótipo 3 e 2,7 por cento ao genótipo 2. A subnotificação de casos de hepatite C foi de 35,5 por cento.
The study was aimed at estimating the prevalence of infection with and the genotype of hepatitis C virus (HCV), and to determine the extent of underreporting of HCV cases. A total of 115,386 pregnant women seen by the Program for Protection of Pregnancy [Programa Estadual de Proteção à Gestante] of the state of Mato Grosso do Sul, Central-Western Brazil, were tested for anti-HCV antibodies between 2005 and 2007. Prevalence of HCV infection was 1.07 cases per thousand. Positive samples were tested for HCV RNA and genotyped. Genotype 1 was detected in 73 percent of samples, genotype 3 in 24.3 percent, and genotype 2 in 2.7 percent. Underreporting of hepatitis C cases was 35.5 percent.
El estudio tuvo por objetivo estimar la prevalencia de la infección y genotipo del virus de la hepatitis C (HCV), así como determinar la subnotificación de casos. El total de 115.386 gestantes atendidas por el Programa Estatal de Protección a la Gestante de Mato Grosso do Sul (Centro-Oeste de Brasil) fueron sometidas a la colecta de sangre para la detección de anti-HCV, de 2005 a 2007. La prevalencia de la infección por el HCV fue de 1,07 casos/1000. Las muestras positivas fueron sometidas a la detección del HCV-RNA y genotipadas. El genotipo 1 fue encontrado en 73 por ciento de las muestras, 24,3 por ciento pertenecían al genotipo 3 y 2,7 por ciento al genotipo 2. La subnotificación de casos de hepatitis C fue de 35,5 por ciento.
Sujet(s)
Adulte , Femelle , Humains , Grossesse , Hépatite C , Complications infectieuses de la grossesse , Brésil , Études transversales , Hepacivirus , Hépatite C , Complications infectieuses de la grossesse , Prévalence , Études rétrospectivesRÉSUMÉ
The study was aimed at estimating the prevalence of infection with and the genotype of hepatitis C virus (HCV), and to determine the extent of underreporting of HCV cases. A total of 115,386 pregnant women seen by the Program for Protection of Pregnancy [Programa Estadual de Proteção à Gestante] of the state of Mato Grosso do Sul, Central-Western Brazil, were tested for anti-HCV antibodies between 2005 and 2007. Prevalence of HCV infection was 1.07 cases per thousand. Positive samples were tested for HCV RNA and genotyped. Genotype 1 was detected in 73% of samples, genotype 3 in 24.3%, and genotype 2 in 2.7%. Underreporting of hepatitis C cases was 35.5%.
Sujet(s)
Hépatite C/épidémiologie , Complications infectieuses de la grossesse/épidémiologie , Adulte , Brésil/épidémiologie , Études transversales , Femelle , Hepacivirus/génétique , Hépatite C/virologie , Humains , Grossesse , Complications infectieuses de la grossesse/virologie , Prévalence , Études rétrospectivesRÉSUMÉ
INTRODUCTION: Hepatic disorders caused by dengue infection may progress to severe manifestations, including mortality and morbidity. Cytokines are involved in it, such as the migration inhibitory factor of macrophages (MIF), tumor necrosis factor (TNF), natural killer cells (NK), B lymphocytes, and macrophages. METHODS: This study was carried out from January to April 2007 at a public hospital from the Federal University of Mato Grosso do Sul, Campo Grande, Brazil. Sixty-eight patients were studied concerning hepatic alterations, with 56 reported having classic dengue, 6 with hemorrhagic dengue grade I, and 6 with hemorrhagic dengue grade II. RESULTS: Among the 56 with classic dengue, 83.3% had aspartate aminotransferase (AST) alterations, and 69.6% had altered alanine aminotransferase (ALT). For those with hemorrhagic dengue grade I, 100% had AST alterations, and 83.3% had altered ALT. All the patients with hemorrhagic dengue grade II had AST and ALT alterations. AST variations reached 22.0 and 907.0, with an average value of 164.6. For ALT, we found variations between 25.0 and 867.0, with an average value of 166.07. There had been statistical significance between dengue clinical shapes and hepatic function markers. CONCLUSIONS: We conclude that the infection was predominant in adults, females, and in those with low income and education. The liver enzymes were of larger amount in hemorrhagic dengue, but there was weak statistical evidence of the clinical manifestations and transaminases. Major signs and clinical symptoms were fever, headache, myalgia, arthralgia, weakness, severe pain behind the eyes, and rashes.
Sujet(s)
Marqueurs biologiques/sang , Dengue/complications , Maladies du foie/virologie , Adulte , Sujet âgé , Alanine transaminase/sang , Aspartate aminotransferases/sang , Dengue/sang , Femelle , Humains , Maladies du foie/sang , Mâle , Adulte d'âge moyen , Dengue sévère/sang , Dengue sévère/complications , Indice de gravité de la maladie , Facteurs socioéconomiques , Jeune adulteRÉSUMÉ
A infecção causada pelo vírus da hepatite B (HBV) é um importante problema de saúde pública no mundo. Neste estudo, uma investigação soroepidemiológica e molecular foi realizada em 12 comunidades afro-descendentes no Brasil Central, as quais se mantêm como isoladas desde o período da escravidão. Amostras de soro de 1058 afro-descendentes foram triadas para os marcadores sorológicos da hepatite B. A prevalência global da infecção pelo HBV foi de 19,8por cento (IC 95por cento: 17,5-22,3), com variação de 5,5por cento (comunidade de Boa Sorte/BS) a 42,4por cento (comunidade de Furnas dos Dionísios/FD). A análise multivariada dos fatores de risco revelou associação significativa entre a infecção causada pelo HBV e o aumento da idade, atividade sexual e história de hepatite na família. A infecção oculta pelo HBV foi...Os isolados do HBV da comunidade de FD foram caracterizados por diferentes perfis de restrição (RFLP) e análise filogenética da região pré-S/S, sendo a maioria destes identificados como pertencentes ao genótipo A, subtipo Aa (HBV/Aa-FD), o que sugere a origem africana para os mesmos. A análise genética...Esses resultados indicam que os isolados HBV/Aa circulantes na comunidade FD foram introduzidos na comunidade por diferentes fontes, provavelmente durante o tráfico de escravos da África para o Brasil. Além disso...Analisando, ainda...foram demonstradas pela análise da seqüência de aminoácidos presentes nas regiões pré-S/S e parte da polimerase. Para elucidar a elevada prevalência de anti-HBe entre os isolados HBsAg-positivos, as regiões promotor do core e pré-core dessas amostras foram seqüenciadas, demonstrando a presença de algumas mutações que justificam o fenótipo anti-HBe. Finalmente, com intuito de avaliar a adesão e resposta à vacina contra hepatite B, 708 afro-descendentes de 8 comunidades foram vacinados. Embora, 567 (80por cento) tenham recebido a primeira dose, somente 198 (28por cento) receberam o esquema vacinal completo. De 148 indivíd...
Sujet(s)
Humains , , Hépatite B/épidémiologie , Épidémiologie moléculaire , Virus de l'hépatite B/génétique , Brésil/épidémiologieRÉSUMÉ
OBJECTIVE: To study the clinical characteristics of 12 patients with paracoccidioidomycosis (PCM) and human immunodeficiency virus (HIV) infection. METHODS: The clinical manifestations, diagnosis, treatment, and outcome of PCM in 12 patients infected with HIV attended at a University Hospital of Mato Grosso do Sul, Brazil, were evaluated. RESULTS: All patients were men, mean age 36.1 years old, and 11 had a diagnosis other than PCM as the aids-defining illness. Lymph nodes were the organs most often involved (10 patients, 83.3%), followed by lung involvement, usually with an interstitial pattern (seven patients, 58.3%), papule-nodular skin lesions with central ulceration in six (50%) and ulcerated lesions of oral mucous membrane in five (41.6%) patients. Pleural involvement occurred in one patient who presented large pleural effusion beside a pathologic rib fracture caused by P. brasiliensis. Seven patients showed involvement in more than one extrapulmonary organ. In eight (66.6%) cases the diagnosis was established by direct microscopy of clinical specimens. All patients used trimethoprim-sulfamethoxazole and seven patients were also treated with amphotericin B. Eight patients died with progressive PCM manifestations. CONCLUSION: Our review demonstrates that PCM, an endemic systemic mycosis in Brazil, when associated with AIDS, behaves clinically as an opportunistic disease.